Solid tumors consist of cancer cells and stromal cells, including resident and transiting immune cellsâall ensconced in an extracellular matrix (ECM)ânourished by blood vessels and drained by lymphatic vessels. The microenvironment constituents are abnormal and heterogeneous in morphology, phenotype, and physiology. Such irregularities include an inefficient tumor vascular network comprised of leaky and compressed vessels, which impair blood flow and oxygen delivery. Low oxygenation in certain tumor regionsâor focal hypoxiaâis a mediator of cancer progression, metastasis, immunosuppression, and treatment resistance. Thus, repairing an abnormal and heterogeneous microenvironmentâand hypoxia in particularâcan significantly improve treatments of solid tumors. Here, we summarize two strategies to reengineer the tumor microenvironment (TME)âvessel normalization and decompressionâthat can alleviate hypoxia. In addition, we discuss how these two strategies alone and in combination with each otherâor other therapeutic strategiesâmay overcome the challenges posed by cancer heterogeneity.